Vanguard Personalized Indexing Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Buy	+11,245	New	+$143K	﹤0.01%	1890
2025 Q4	–	Sell	-10,995	Closed	-$190K	–	2041
2025 Q3	$190K	Buy	10,995 +718	+7%	+$8.84K	﹤0.01%	1721
2025 Q2	$96.4K	Sell	10,277 -931	-8%	-$7.64K	﹤0.01%	1746
2025 Q1	$79.7K	Buy	+11,208	New	+$113K	﹤0.01%	1641
2024 Q2	–	Sell	-8,944	Closed	-$246K	–	1728
2024 Q1	$246K	Buy	8,944 +2,197	+33%	+$61K	0.01%	1360
2023 Q4	$206K	Buy	+6,747	New	+$194K	0.01%	1405
2023 Q3	–	Sell	-5,854	Closed	-$239K	–	1535
2023 Q2	$239K	Sell	5,854 -972	-14%	-$39.4K	0.01%	1249
2023 Q1	$254K	Buy	+6,826	New	+$268K	0.01%	1199
2022 Q4	–	Sell	-6,546	Closed	-$366K	–	1311
2022 Q3	$366K	Buy	6,546 +274	+4%	+$17K	0.02%	894
2022 Q2	$325K	Buy	6,272 +2,424	+63%	+$123K	0.02%	959
2022 Q1	$280K	Buy	3,848 +1,375	+56%	+$116K	0.01%	1017
2021 Q4	$292K	Sell	2,473 -1,186	-32%	-$149K	0.02%	872
2021 Q3	$491K	Buy	+3,659	New	+$554K	0.04%	523